Category: Research
-
![Xphyto (XPHY.C) advances delivery system for Parkinson’s drug]()
Xphyto (XPHY.C) advances delivery system for Parkinson’s drug
Vektor is now proceeding with process implementation for the manufacture of Rotigotine patches for human clinical studies.
-
Do not adjust your TV sets – Heritage Cannabis (CANN.C) is a real business
New licenses, deals, products – that’s all good – but it’s not the nitty gritty stuff investors are looking for now. By “nitty-gritty” we mean – numbers. Four weeks ago, Heritage released its Q1, 2020 financials.
-
The real reason for XPhyto’s (XPHY.C) freaky gravity-defying chart
XPHY owns a German narcotic manufacturer called Vektor Pharma, another subsidiary called Bunker that has all the licenses to study cannabis as a medicine, and it has formed multiple partnerships with universities and research centers.
-
![Xphyto (XPHY.C) blowing the weed sector out of the water with true 2.0 plan]()
Xphyto (XPHY.C) blowing the weed sector out of the water with true 2.0 plan
Xphyto (XPHY.C) is dominating the cannabis sector like Sean Kemp used to dominate the Seattle buffet scene. It’s a legit beast right now, jumping from fat new high to fat new high. We’ve sat with their team several times over the past year and on each occasion have been impressed with their plans, but perhaps…
-
New Experion (EXP.V) CEO lays out the real definition of cannabis 2.0… cost controls and common sense
Sick of hearing about how cannabis companies are ‘on the cusp of something great’ and ‘leading the industry’? Well Experion’s new CEO has gone another way: Truth.
-
Isracann’s (IPOT.C) JV with a “late stage farm” could double cannabis production in Israel
On December 17, 2019 Isracann (IPOT.C) announced that it has entered into an Memorandum of Understanding (MOU) for a joint venture (JV) with an additional cannabis farm property in Israel. Isracann is already constructing a 230,000 square-foot facility in southern Israel. It’s received facility design and land use approvals from the Israeli government and is…
-
![CLS Holdings (CLSH.C) completes phase 1 of Las Vegas cannabis facility]()
CLS Holdings (CLSH.C) completes phase 1 of Las Vegas cannabis facility
On December 5, 2019 CLS Holdings (CLSH.C) announced that it has completed the buildout and licensing for phase 1 of its north Las Vegas processing facility. The CLS business model includes licensing, extraction, processing, sale of products, brand creation and consulting services. CLSH has developed a proprietary method of extracting cannabinoids from cannabis plants and…
-
![Chemesis (CSI.C) Q1, 2020 cannabis revenue up 279% – official “survivor” status?]()
Chemesis (CSI.C) Q1, 2020 cannabis revenue up 279% – official “survivor” status?
On January 10, 2018 (almost two years ago), the Canadian Marijuana Index peaked just north of a 1,000. At that time, the valuation of almost every cannabis company looked rich. Today, the Canadian Marijuana Index is at 212 (down 80%). These days, the pom-poms are locked firmly in a drawer, but it is worth pointing…
-
![SOL Global (SOL.C) revs up in Florida, financials dragged down by Verano investment]()
SOL Global (SOL.C) revs up in Florida, financials dragged down by Verano investment
On December 2, 2019 Sol Global (SOL.C) released its Q2, financial results for the three and six-month period ended September 30, 2019. SOL Global invests in cannabis related companies in legal U.S. states, hemp and CBD marketplaces and the emerging European cannabis and hemp territories. Its business activities encompass cultivation, distribution, retail – and an…
-
Pivot Pharma (PVOT.C): can a new CEO turn a cannabis science co. into a profit machine?
Perusing Pivot Pharmaceuticals’ (PVOT.C) website you might think you’ve stumbled onto Pfizer’s (PFE.NYSE) “Proprietary IP” link. “RTIC infused substrates”? “Supercritical extraction”? “Phospholipid bilayers”? Anyone? In fact, if you strip away the tech-talk – Pivot’s business model is not that hard to wrap your head around. Pivot is a “science-based medical wellness company” that has developed…
